Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-21-003782

Options or other derivatives

  • President & CEO acquired 185,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-04 Grant or award : show line 1 in the form Stock Option (Right to Buy) +185,000 $62.32 2031-02-03 185,000 185,000 D
Loading xslF345X03/form4.xml…